Atlas Trials

PD-1 Monoclonal Antibody in Pre-treated Lymphoepithelioma-like Carcinoma

Clinical trial NCT04430166 · UNKNOWN

Trial details

NCT number
NCT04430166
Sponsor
Guangzhou University of Traditional Chinese Medicine
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Lymphoepithelioma-Like Carcinoma
Start date
2020-06-01
Primary completion
2022-09-01
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.